StockData
NovaBridge Biosciences logo

NovaBridge Biosciences (NBP) stock

NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.83−0.05 (-5.66%)

Close on Nov 20, 2026Market cap $95.77MP/E –Yield –

NovaBridge Biosciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2022 it was -CN¥248.80M, down 698.2% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2022Dec 31, 2022-CN¥248.80M-698.2%
FY2021Dec 31, 2021CN¥41.59M-97.3%
FY2020Dec 31, 2020CN¥1.54B+5042.2%
FY2019Dec 31, 2019CN¥30.00M–

More NovaBridge Biosciences figures

See a number that looks wrong?